|
Market Closed -
Nasdaq
16:30:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 2.900 USD | -2.36% |
|
+0.35% | -62.44% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.88% | -0.34% | -10.10% | +16.80% | +61.08% | +40.64% | +73.05% | +5.19% | - | 65.28B | |
| -0.21% | -0.26% | -7.86% | -1.47% | +8.57% | +9.51% | +77.02% | +223.71% | +5,419.15% | 54.57B | |
| -0.50% | +0.90% | +7.94% | +12.73% | +17.26% | +8.99% | +100.45% | -16.48% | +256.67% | 53.59B | |
| -2.06% | +2.90% | +1.19% | +31.51% | +21.38% | +24.07% | +48.36% | +6.84% | +274.18% | 45.03B | |
| -1.79% | +0.19% | +2.78% | +13.80% | +22.07% | +19.32% | +123.62% | -3.33% | +1,026.92% | 42.17B | |
| -1.65% | +0.96% | -10.28% | -2.82% | +130.89% | +237.56% | +823.66% | +577.85% | - | 39.42B | |
| -2.26% | -4.14% | +7.10% | +6.98% | +10.22% | +15.38% | +45.53% | +3.86% | +156.29% | 32.71B | |
| -2.70% | -10.77% | -16.37% | +15.52% | +42.05% | +19.80% | -6.47% | -61.99% | - | 24.01B | |
| +0.57% | +14.30% | +29.19% | +55.87% | +46.72% | +59.04% | +48.18% | +2.41% | +160.42% | 26.5B | |
| -1.42% | -2.63% | -11.84% | -2.77% | -8.76% | -17.79% | -10.12% | -70.29% | - | 21.82B | |
| -0.06% | -2.06% | -20.79% | -12.71% | -46.37% | -41.54% | +265.28% | +247.47% | +566.64% | 20.38B | |
| +1.13% | +9.22% | +9.35% | +12.54% | +20.50% | +11.83% | +164.49% | +217.70% | +2,180.99% | 18.93B | |
| +3.45% | +19.08% | +22.00% | +57.68% | +79.10% | +81.32% | +104.07% | -16.88% | +358.10% | 17.06B | |
| -0.63% | +8.00% | +8.38% | +27.50% | +36.73% | +38.55% | +84.36% | -16.68% | +107.19% | 16.69B | |
| +0.90% | +3.88% | +11.95% | +17.59% | +48.55% | +68.16% | +210.20% | +200.60% | +482.38% | 16.13B | |
| +0.73% | +6.61% | +8.67% | -3.43% | - | - | - | - | - | 16.1B | |
| -1.28% | -1.28% | +0.43% | +2.20% | +173.78% | +155.82% | +363.62% | +1,373.64% | +757.63% | 14.75B | |
| -0.80% | +9.30% | +6.64% | +10.87% | +0.86% | +3.18% | -23.60% | -35.55% | +125.72% | 14.18B | |
| -5.62% | -3.16% | -0.44% | -11.74% | +15.55% | +5.49% | +488.95% | - | - | 14.63B | |
| Average | -0.71% | +3.85% | +2.00% | +12.98% | +37.79% | +41.07% | +165.59% | +155.18% | +913.25% | 29.15B | |
| Weighted average by Cap. | -0.71% | +3.09% | +0.28% | +13.13% | +36.84% | +40.91% | +155.95% | +121.11% | +1,223.38% |
- Stock Market
- Stocks
- ADXN Stock
- ADXN Stock
- Sector Addex Therapeutics Ltd
Select your edition
All financial news and data tailored to specific country editions
